Evidence map›Paper›PMID 40091357›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

CCL20/CXCL5 Drives Crosstalk Between Anaplastic Thyroid Cancer Stem Cells and Tumor-Associated Macrophages to Promote Tumor Progression.

Qi Liu, Yan Wang, Mingyuan Song, Jiapeng Huang, Jinyuan Shi, Wei Sun, Xiaoyu Ji, Yuang Chang, Bing Ma, Ping Zhang and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qi LiuDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Yan WangDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, P. R. China.
Mingyuan SongDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Jiapeng HuangDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Jinyuan ShiDepartment of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, P. R. China.
Wei SunDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Xiaoyu JiDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Yuang ChangDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Bing MaDepartment of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Ping ZhangDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.
Yuanyuan YanDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, P. R. China.
Hao ZhangDepartment of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, 110801, P. R. China.ORCID https://orcid.org/0000-0002-9938-8433

Funding

Applied Basic Research Program of Liaoning Province 2022020225-JH2/1013National Natural Science Foundation of China 82303670Natural Science Foundation of Liaoning Province 2023-MS-156
6 · The paper itself

Abstract

The dynamic interplay between tumor-associated macrophages (TAMs) and anaplastic thyroid cancer (ATC) shapes the tumor microenvironment and facilitates ATC progression. However, the mechanisms of communication between TAMs and anaplastic thyroid cancer stem cells (ATCSCs) remain largely unelucidated. Integrative analyses of single-cell RNA sequencing, cytokine/chemokine arrays, proteomics, and mRNA expression datasets are performed to reveal crosstalk between TAMs and ATCSCs and signaling pathways in ATCSCs. Subsequently, in vitro experiments are performed to validate the regulatory effects of key cytokines on ATCSC stemness. Last, xenogeneic orthotopic thyroid ATCSCs transplantation models are utilized to corroborate the regulatory effect of cytokines on stemness. CCL20 derived from THP-1-M2 activates the IRAK-1/NF-κB1/2 signaling pathway in ATCSCs, thereby positively regulating stemness characteristics and upregulating CXCL5 secretion. ATCSCs not only exhibit autocrine CXCL5 participation in the regulation of stemness but also demonstrate paracrine CXCL5 activity to recruit THP-1-Mφ and maintain the M2 phenotype. CCL20 and CXCL5 are involved in the crosstalk between TAMs and ATCSCs. The CCL20/CXCL5 axis plays a crucial role in the interaction between TAMs and ATCSCs, establishing a progressive tumor microenvironment.

Indexed as

Chemokine CCL20Chemokine CXCL5Neoplastic Stem CellsThyroid Carcinoma, AnaplasticThyroid NeoplasmsTumor-Associated MacrophagesAnimalsCell Line, TumorDisease ProgressionHumansMiceSignal TransductionTumor MicroenvironmentCCL20 protein, humanChemokine CCL20Chemokine CXCL5CXCL5 protein, humananaplastic thyroid cancercancer stem cellCCL20crosstalkCXCL5tumor microenvironment

Identifiers

PMID40091357
PMCPMC12061268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.